Michigan Medicine

Futó vizsgálatok

• Még nem toboroz

  R-2487 in Patients With Sjogren's Syndrome (SjD)

  NCT06297213· 1. fázis· Rise Therapeutics LLC· Forrás

• Még nem toboroz

  Rethinking Early Airway Clearence Therapies

  NCT07696338· Nicole Hamblett· Forrás

• Toboroz

  Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)

  NCT07582861· Carelon Research· Forrás

• Toboroz

  BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease

  NCT07582848· Carelon Research· Forrás

• Toboroz

  ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

  NCT07531745· 1/2. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Toboroz

  Phase 2 Study to Assess the Safety and Efficacy of ANG003

  NCT07450547· 2. fázis· Anagram Therapeutics, Inc.· Forrás

• Toboroz

  A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

  NCT07525843· Carelon Research· Forrás

• Toboroz

  Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation

  NCT05991700· 1/2. fázis· University of Michigan· Forrás

• Toboroz

  A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  NCT07432958· 2. fázis· Appello Pharmaceuticals, Inc.· Forrás

• Toboroz

  Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  NCT07230288· 2. fázis· AbbVie· Forrás

• Toboroz

  Diagnosing Epilepsy To EffeCT Change

  NCT07110337· Epiminder America, Inc.· Forrás

• Toboroz

  Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

  NCT07110454· Epiminder America, Inc.· Forrás

• Toboroz

  Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

  NCT07265947· 2. fázis· Tyra Biosciences, Inc· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  NCT07285460· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07023627· 2. fázis· Incyte Corporation· Forrás

• Toboroz

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  NCT07190209· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

  NCT07023289· 2. fázis· AbbVie· Forrás

• Toboroz

  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  NCT06975865· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study of Dotinurad Versus Allopurinol in Participants With Gout

  NCT07089875· 3. fázis· Crystalys Therapeutics· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  NCT06953960· 1/2. fázis· AbbVie· Forrás

• Toboroz

  Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  NCT06911632· Tempus AI· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Toboroz

  A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  NCT06901531· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients

  NCT06677151· University of Michigan· Forrás

• Toboroz

  Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  NCT06654752· University of Washington, the Collaborative Health Studies Coordinating Center· Forrás

• Fut, nem toboroz

  Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

  NCT06676319· 2. fázis· Sanofi· Forrás

• Meghívásos bevonás

  Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

  NCT06609239· 2. fázis· Sanofi· Forrás

• Toboroz

  Registry for Stage 2 Type 1 Diabetes

  NCT06481904· Sanofi· Forrás

• Toboroz

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Nicole Hamblett· Forrás

• Fut, nem toboroz

  Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

  NCT06572228· 4. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

  NCT06524635· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

  NCT06347159· 2. fázis· Edgewise Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

  NCT06048133· 2. fázis· Nataliya Uboha· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

  NCT06241118· 3. fázis· Sanofi· Forrás

• Toboroz

  Zenith® Fenestrated+ Clinical Study

  NCT04875429· Cook Research Incorporated· Forrás

• Toboroz

  Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

  NCT05929703· University of Michigan· Forrás

• Fut, nem toboroz

  An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

  NCT06117891· Bayer· Forrás

• Toboroz

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Toboroz

  A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

  NCT06016842· 3. fázis· Ipsen· Forrás

• Toboroz

  Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  NCT05548283· 4. fázis· Chris Goss· Forrás

• Fut, nem toboroz

  Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib

  NCT05323955· 2. fázis· Carey Anders, M.D.· Forrás

• Fut, nem toboroz

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

  NCT05455320· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Colorectal Cancer Screening in Cystic Fibrosis

  NCT05362344· University of Washington, the Collaborative Health Studies Coordinating Center· Forrás

• Toboroz

  A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

  NCT05379595· 1/2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

  NCT05389215· 2. fázis· Daewoong Pharmaceutical Co. LTD.· Forrás

• Fut, nem toboroz

  Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  NCT05316701· 3. fázis· Orca Biosystems, Inc.· Forrás

Showing 50 of 78.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Cisztás fibrózis6 toboroz
• Congenital heart disease3 toboroz
• Epilepszia3 toboroz
• Mielóma multiplex3 toboroz
• Szívelégtelenség3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Elhízás2 toboroz
• Krónikus vesebetegség2 toboroz
• Vastagbélrák2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Alzheimer-kór1 toboroz
• Amiloidózis1 toboroz
• Aortic aneurysm1 toboroz
• Asztma1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Gout1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hemofília1 toboroz
• Hidradenitis suppurativa1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hólyagrák1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Magas vérnyomás1 toboroz
• Obstructive sleep apnoea1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Prosztatarák1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Sjögren-szindróma1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

  NCT06383403· 3. fázis· Ipsen· Forrás

• Lezárult

  Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

  NCT06506773· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

  NCT06333860· 4. fázis· AbbVie· Forrás

• Lezárult

  A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

  NCT06229145· 4. fázis· Amgen· Forrás

• Lezárult

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· 2. fázis· Sanofi· Forrás

• Lezárult

  Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

  NCT05855109· Boehringer Ingelheim· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Lezárult

  Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

  NCT06102005· 2. fázis· Sanofi· Forrás

• Leállították

  CD40L Antagonism in Rheumatoid Arthritis (RA)

  NCT05306353· 2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

  NCT05574400· 2. fázis· University of Michigan· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

  NCT05453578· 1/2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Leállították

  Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma

  NCT05359861· 2. fázis· Coherus Oncology, Inc.· Forrás

• Lezárult

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

• Lezárult

  Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

  NCT04724369· 3. fázis· Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)· Forrás

• Lezárult

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Leállították

  COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

  NCT05000216· 2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Lezárult

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

  NCT04744831· 2. fázis· Daiichi Sankyo· Forrás

• Lezárult

  Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

  NCT04230499· 2. fázis· Rapamycin Holdings Inc.· Forrás

• Visszavonták

  Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT04607772· 1/2. fázis· Karyopharm Therapeutics Inc· Forrás

• Lezárult

  A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

  NCT04322539· 3. fázis· Hutchison Medipharma Limited· Forrás

• Lezárult

  Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

  NCT04374877· 1. fázis· Coherus Oncology, Inc.· Forrás

• Lezárult

  A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function

  NCT04038047· Nicole Hamblett· Forrás

• Lezárult

  Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113

  NCT04070768· 1. fázis· John Quigley· Forrás

• Lezárult

  Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  NCT03709680· 2. fázis· Pfizer· Forrás

• Leállították

  Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

  NCT03322345· University of Michigan· Forrás

• Lezárult

  Myeloma-Developing Regimens Using Genomics (MyDRUG)

  NCT03732703· 1/2. fázis· Multiple Myeloma Research Consortium· Forrás

• Lezárult

  STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

  NCT03489629· 2. fázis· University of North Carolina, Chapel Hill· Forrás

• Lezárult

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

  NCT02621151· 2. fázis· NYU Langone Health· Forrás

• Lezárult

  Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

  NCT02824029· 2. fázis· Barbara Ann Karmanos Cancer Institute· Forrás

• Lezárult

  AASUR in High Risk Prostate Cancer

  NCT02772588· 2. fázis· Memorial Sloan Kettering Cancer Center· Forrás

• Lezárult

  Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

  NCT02467270· 2. fázis· Takeda· Forrás

• Lezárult

  PD 0332991 and Cetuximab in Patients With Incurable SCCHN

  NCT02101034· 1/2. fázis· Washington University School of Medicine· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Pfizer· Forrás

• Lezárult

  A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

  NCT01740427· 3. fázis· Pfizer· Forrás

• Lezárult

  An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

  NCT01592370· 1/2. fázis· Bristol-Myers Squibb· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szívelégtelenség119 munka · 3 vizsgálat
• 2-es típusú cukorbetegség72 munka · 3 vizsgálat
• Krónikus vesebetegség65 munka · 2 vizsgálat
• Cisztás fibrózis56 munka · 17 vizsgálat
• Asztma50 munka · 5 vizsgálat
• Krónikus obstruktív tüdőbetegség (COPD)36 munka · 1 vizsgálat
• Szisztémás szklerózis (szkleroderma)32 munka · 1 vizsgálat
• Idiopátiás tüdőfibrózis29 munka · 4 vizsgálat
• 1-es típusú cukorbetegség25 munka · 1 vizsgálat
• Zsírmáj (MASLD/MASH)24 munka · 1 vizsgálat
• Colitis ulcerosa23 munka · 0 vizsgálat
• Irritable bowel syndrome23 munka · 0 vizsgálat
• Fibromyalgia19 munka · 0 vizsgálat
• Obstructive sleep apnoea19 munka · 1 vizsgálat
• Aortic aneurysm19 munka · 1 vizsgálat
• Hearing loss18 munka · 0 vizsgálat
• Aortic stenosis17 munka · 2 vizsgálat
• Insomnia17 munka · 0 vizsgálat
• Cerebral palsy14 munka · 0 vizsgálat
• Endometriózis14 munka · 0 vizsgálat
• Pulmonális artériás hipertónia14 munka · 1 vizsgálat
• Hipertrófiás kardiomiopátia13 munka · 5 vizsgálat
• Pajzsmirigyrák12 munka · 0 vizsgálat
• Fej-nyaki daganatok11 munka · 1 vizsgálat
• Ventricular tachycardia10 munka · 0 vizsgálat
• Meningioma8 munka · 0 vizsgálat
• IgA-nefropátia8 munka · 0 vizsgálat
• Hepatitis B (krónikus)7 munka · 0 vizsgálat
• Dermatomyositis and polymyositis (myositis)6 munka · 1 vizsgálat
• Cushing's syndrome5 munka · 0 vizsgálat